주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, Aprill 26, 2024, 12:03
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Wealth of Korea's 50 Richest on Forbes List Rises to US$115 billion
이미지기사
Social Issues
Yoon Young-sil
04.18 13:52
Market Capitalization Surges by 96 Trillion Won in Q1
이미지기사
Capital Market
Yoon Young-sil
04.17 12:12
Celltrion Completes US Patent Registration for Zymfentra
이미지기사
Healthcare & Bio
Jasmine Choi
04.12 10:16
Foreign Investors Purchase Top Stocks, Sell Secondary Stocks Amid ‘Buy Korea’ Surge
이미지기사
Macro-Economics
Yoon Young-sil
04.09 13:20
Celltrion Obtains Recommendation for Marketing Authorization of Xolair Biosimilar ‘CT-P39’ in Europe
이미지기사
Healthcare & Bio
Jasmine Choi
03.26 07:53
3 Celltrion Drugs Win Tenders by Public Organizations in Peru
이미지기사
Healthcare & Bio
Michael Herh
02.16 13:59
Celltrion Confirms Safety in Phase 1 Trial of Oral Treatment for Autoimmune Diseases
이미지기사
Healthcare & Bio
Choi Mun-hee
02.07 11:17
Samsung Bioepis, Celltrion Entangled in Patent Disputes with Original Pharmaceutical Companies
이미지기사
Healthcare & Bio
Choi Mun-hee
02.02 14:20
Celltrion Applies for US FDA Approval of Actemra Biosimilar CT-P47
이미지기사
Healthcare & Bio
Jasmine Choi
01.30 11:18
Celltrion Partners with China’s WuXi XDC for Joint Development of ADC Therapeutics
이미지기사
Healthcare & Bio
Jasmine Choi
01.25 13:02
Celltrion Group Successfully Sells Takeda Primary Care Business Rights
이미지기사
Healthcare & Bio
Jasmine Choi
01.22 10:38
Celltrion Launches 80 mg Version of Yuflyma in US
이미지기사
Healthcare & Bio
Michael Herh
01.18 12:02
Chairman Seo Jung-jin Announces Plans to List Celltrion Holdings on NASDAQ
이미지기사
Healthcare & Bio
Jasmine Choi
01.16 10:51
Celltrion Achieves Successive Orders for Autoimmune Disease Similars in Europe
이미지기사
Healthcare & Bio
Jasmine Choi
01.12 18:04
Samsung Electronics, SK hynix Witness Remarkable 200 Trillion Won Surge in Market Caps Over Past Year
이미지기사
ICT
Kim Eun-jin
01.12 13:24
Pharmaceutical, Biotech Companies Gather in San Francisco
이미지기사
Healthcare & Bio
비지니스코리아 기자
01.05 10:57
Celltrion Group Announces Strategic Sale of Primary Care Business Acquired from Takeda Pharmaceutical
이미지기사
Healthcare & Bio
Jasmine Choi
01.03 08:38
Integrated Celltrion to Launch: Global Big Pharma Firm with 12 Trillion Won Revenue
이미지기사
Healthcare & Bio
Choi Mun-hee
2023.12.28 09:09
Celltrion Announces Phase 3 Clinical Trial Results for CT-P17, Humira
이미지기사
Healthcare & Bio
Jasmine Choi
2023.12.27 15:14
Celltrion Announces 500 Won Per Share Dividend Alongside Share Cancellation Next Month
이미지기사
Healthcare & Bio
Choi Mun-hee
2023.12.14 10:51
처음
1
2
3
4
5
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기